Skip to main content

Bioceres Crop Solutions Corp. (BIOX)

Sector
Basic Materials
Industry
Agricultural Inputs
Last price
$0.23
As of

Kresmion compiles this page from BIOX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Bioceres Crop Solutions Corp. (BIOX): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 20-F filed 2026-10-30.

As of . Source: SEC EDGAR filings for BIOX. Method and limitations.

COMPANY DOSSIER

See the full BIOX dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for BIOX on one page. Preview it with sample data, then open it live with a free account.

Preview the BIOX dossier

Active events for BIOX

FREE, NO ACCOUNT

Every event on BIOX, as it fires

You are seeing 5 of 8 events recorded on BIOX since 2026-06-10.

The five above landed across 3 days. The other 3 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

BIOX positions held by the managers we follow (2026Q2)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
TWO SIGMA INVESTMENTS, LP FundCUSIP G1117K114 · 2026Q2$11K0.00%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, BIOX

Going concern statement

BIOX's 20-F filed Oct 30, 2026 states:

We face substantial liquidity constraints and there is substantial doubt regarding our ability to continue as a going concern.

Read the 20-F on SEC EDGAR Every company with a going concern statement

More data on BIOX

BIOX against its peers

BIOX's operating margin of -0.7% ranks in the 58th percentile of 5 Agricultural Inputs sub-industry peers, fiscal periods ending between 2025-06-30 and 2025-12-31.

MetricBIOXPeer medianPercentilen
Revenue FY335M USD515M USD425
Revenue YoY-27.9%n/an/a2
Gross margin39.3%29.6%646
Operating margin-0.7%-5.5%585
Net margin-16.5%-34.0%506
Return on equity-20.9%n/an/a4

Peers (8): SEED, GNVR, AVD, VRDR, PUBC, NXTS, UAN, ICL. Left out: SGTM (no annual filing), EMRH (no annual filing), LVROF (period gap), YARIY (no annual filing), CTA-PB (no annual filing). Fiscal periods ending between 2025-06-30 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (BIOX: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in BIOX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BIOX in the last 180 days.

Upstream: SEC EDGAR filings for BIOX

Kresmion, "Bioceres Crop Solutions Corp. (BIOX) institutional holdings and SEC filings", data as of 2026-10-30, https://kresmion.com/research/BIOX. Upstream data: SEC EDGAR filings for BIOX.

Link to this data (HTML):

<a href="https://kresmion.com/research/BIOX">Bioceres Crop Solutions Corp. (BIOX) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow BIOX on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BIOX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the BIOX dossier
Share

The BIOX intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.